Medical Applications

Video about metrology solutions for medical components

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Tablet treatment for hair loss approved in the USA

The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

She is Sweden´s new Minister of Healthcare

Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new mi...

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

Drug development creates new challenges for regulators

Yxan går hos läkemedelsjätte – över 2 000 jobb ska bort

Bristol Myers Squibb planerar stora neddragningar. Omkring 2 200 av bolagets anställda väntas få gå när läkemedelsjätten ska skära i kostnaderna.

Novo Nordisk buys drug candidate in billion dollar deal

The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

Lundbeck behind the first EU-approved intravenous migraine treatment

A preventive, intravenous treatment for migraines has been approved in the EU for the first time.

EMA-granskning bekräftar risk för ny cancer efter CAR-T

CAR-T-terapier mot cancer kan i sällsynta fall ge upphov till sekundära cancersjukdomar. Det slås nu fast av den europeiska läkemedelsmyndigheten EMA, som kräve...

A billion-dollar acquisition makes Novo Nordisk even bigger in obesity

Danish pharmaceutical giant Novo Nordisk acquires Montreal-based Inversago Pharma, which develops treatments for obesity and diabetes.

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Behandling av prostatacancer får positivt EU-utlåtande

Prostataläkemedlet Xtandi har nu fått ett positivt utlåtande i EU av den europeiska läkemedelsmyndigheten EMA:s rådgivande grupp CHMP.

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

Högteknologiska bolag allt mer intresserade av hälsa

Under många år har techföretag intresserat sig för hälso- och sjukvården och det intresset ser ut att öka. ”Det är inget plötsligt trendbrott, det handlar mer o...

Krönika: Collaboration across borders